NCT06221605View on ClinicalTrials.gov

Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

March 10, 2025

Study Completion Date

April 11, 2025

Conditions
Chronic Hepatitis B
Interventions
DIETARY_SUPPLEMENT

Probiotic

The intervention lasted for 3 months and 3 visits (at 0 month, 3rd and 6th month respectively).

Trial Locations (1)

200000

Huashan Hospital Affiliated with Fudan University, Shanghai

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY

NCT06221605 - Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial | Biotech Hunter | Biotech Hunter